Submit Deal

SPARROW PHARMACEUTICALS

HQ - Portland, OR

Summary

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company that develops targeted therapies for unmet medical needs in endocrinology and rheumatology.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 45 M

Avg. Deal Size£ 45 M

Market Context

Senior Management

David Katz
CEO

Sort

01 Jul 2025|United States|Pharmaceuticals

Target: SPARROW PHARMACEUTICALS

Bidder: ORBIMED PE

5 Service Providers

2 Target | 3 Bidder

4 Dealmakers

1 Target | 3 Bidder

£ 45 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy